Enveda secures $311M to bring more nature-derived AI drugs into clinical trials

TechCrunch - Sep 23, 2026

The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.

Read full article

More News

White House Backtracks on Plan to Exert New Control Over N.I.H. Grants

White House Backtracks on Plan to Exert New Control Over N.I.H. Grants

White House Backtracks on Plan to Exert New Control Over N.I.H. Grants

White House Backtracks on Plan to Exert New Control Over N.I.H. Grants

The New York Times stopped publishing White House pool photos in support of the banned outlets.

The New York Times stopped publishing White House pool photos in support of the banned outlets.

AI leaders warn UN of security risks as systems grow more powerful

Trump’s Energy Secretary Dismisses Reports of Diesel Export Ban, Criticizes Solar Power

Trump’s Energy Secretary Dismisses Reports of Diesel Export Ban, Criticizes Solar Power

Florida Files Lawsuit Against The New York Times

Florida Files Lawsuit Against The New York Times

The judge in this case once restored White House access for a CNN reporter after Trump stripped it.

The judge in this case once restored White House access for a CNN reporter after Trump stripped it.

Bentley unveils its first fully electric car

Bentley unveils its first fully electric car

Here’s what the news outlets and the White House have said in court papers.

Here’s what the news outlets and the White House have said in court papers.

Barrecore and Boom Cycle owner suddenly shuts studios

Barrecore and Boom Cycle owner suddenly shuts studios

Where Is the U.S. Beating China on A.I., and Where Is It Lagging?

Where Is the U.S. Beating China on A.I., and Where Is It Lagging?

Where Is the U.S. Beating China on A.I., and Where Is It Lagging?

Where Is the U.S. Beating China on A.I., and Where Is It Lagging?

Recommended